Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TP63 | hg38_v1_chr3_+_189789672_189789681 | 0.39 | 2.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_119431846 Show fit | 5.64 |
ENST00000306406.5
|
transmembrane protein 37 |
|
chr1_-_153615858 Show fit | 4.38 |
ENST00000476873.5
|
S100 calcium binding protein A14 |
|
chr1_-_47190013 Show fit | 4.15 |
ENST00000294338.7
|
PDZK1 interacting protein 1 |
|
chr19_+_18386150 Show fit | 3.94 |
ENST00000252809.3
|
growth differentiation factor 15 |
|
chr6_-_46954922 Show fit | 3.92 |
ENST00000265417.7
|
adhesion G protein-coupled receptor F5 |
|
chr7_+_80638510 Show fit | 3.82 |
ENST00000433696.6
ENST00000538969.5 ENST00000544133.5 |
CD36 molecule |
|
chr11_+_18266254 Show fit | 3.74 |
ENST00000532858.5
ENST00000649195.1 ENST00000356524.9 ENST00000405158.2 |
serum amyloid A1 |
|
chr10_-_88991282 Show fit | 3.61 |
ENST00000458159.5
ENST00000415557.1 |
actin alpha 2, smooth muscle |
|
chr11_-_111911759 Show fit | 3.61 |
ENST00000650687.2
|
crystallin alpha B |
|
chrX_+_2752024 Show fit | 3.52 |
ENST00000644266.2
ENST00000419513.7 ENST00000509484.3 ENST00000381174.10 |
Xg glycoprotein (Xg blood group) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 10.2 | GO:0070543 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.4 | 7.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.3 | 6.7 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
0.2 | 6.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 5.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 4.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 4.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 4.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 4.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.1 | 4.1 | GO:0010107 | potassium ion import(GO:0010107) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.0 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 8.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 7.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 6.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 5.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 5.0 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 4.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.6 | 4.0 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 3.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 3.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 10.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.8 | 10.2 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 7.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.0 | 6.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 6.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 5.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 5.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 5.2 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 4.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 14.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 11.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 6.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 6.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 3.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 3.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 3.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 3.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 5.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 5.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 5.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 4.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 3.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 3.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 3.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 3.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 3.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |